The spreadsheet you attached included the 3 from the trials (which indicated that there were 14 at the end of July). However, the way Biogen was counting, they did not include the 3 from the trials in their weekly summary's that they were posting on their website until July 23rd. Their count was "11" because they excluded the 3 from the trials.

In late Sept there were two more announced by the FDA, bringing the total to 13 (or 16 including the trial patients).

Then the story broke on 10 more about a week and a 1/2 ago, bringing the total to 23 (or 26 including the trial patients).

Last week there was an announcement of one more, bringing the total to 24 (or 27 including the trial patients).

Many of those links are on this forum already, but I can put them all here if that will help ...?

Cherie